Severe esophagitis induced by antituberculosis drugs: a case report.
Roxana Flores MamaniFranciele Moreira SilvaMarcos Vidal de Lima-JúniorJuliana Paitach de Oliveira LimaVitor Montez ViannaRivelino Trindade de AzevedoBilly McBenedictEzequias Batista MartinsPublished in: Revista do Instituto de Medicina Tropical de Sao Paulo (2024)
Tuberculosis stands as one of humanity's oldest afflictions, intrinsically intertwined with social disparities. This formidable disease spares no age group and remains the prevailing cause of infection-induced mortality worldwide, particularly in developing nations. We present a case of a 56-year-old woman with diabetes who was diagnosed with Pulmonary Tuberculosis. After receiving antituberculosis drugs as part of her treatment, she experienced a range of systemic manifestations and suffered from severe ulcerative esophagitis. This adverse reaction led to uncontrollable gastrointestinal intolerance, tragically resulting in her untimely demise. The incident underscores the potential seriousness of adverse reactions that can arise from tuberculosis treatment medications.
Keyphrases
- pulmonary tuberculosis
- mycobacterium tuberculosis
- drug induced
- cardiovascular disease
- type diabetes
- healthcare
- early onset
- mental health
- hiv aids
- adverse drug
- risk factors
- replacement therapy
- high glucose
- metabolic syndrome
- insulin resistance
- diabetic rats
- human immunodeficiency virus
- smoking cessation
- weight loss
- endothelial cells